InsidersTradesSigma
Discover the full record of transactions filed by Harr Steve, 董事长兼首席执行官. Director active across 1 company, notably Sana Biotechnology, Inc.. In total, 1 reports have been published. Activity tracked since 14 April 2021. The latest transaction was filed on 14 April 2021 (Don). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Steve Harr is the President & CEO of Sana Biotechnology, Inc. He leads the company with a vision focused on innovation and the development of new therapies. His leadership is essential to achieve the company's growth and impact objectives.